Does a nanomolecule of Carboplatin injected periocularly help in attaining higher intravitreal concentrations?
- PMID: 19628744
- DOI: 10.1167/iovs.09-3914
Does a nanomolecule of Carboplatin injected periocularly help in attaining higher intravitreal concentrations?
Abstract
Purpose: To compare intravitreal concentration (VC) of commercially available carboplatin (CAC) and the novel nanomolecule carboplatin (NMC), after periocular injection.
Methods: The study was a comparative animal study involving 24 white Sprague-Dawley rats, aged between 6 weeks and 3 months. CAC was bound with a nanoparticulate carrier by co-acervation with a biocompatible and biodegradable protein BSA (bovine serum albumin). The particulate size, binding, and structure of the carrier was analyzed with dynamic light-scattering electron microscopy, FTIR (Fourier transform infrared) spectroscopy, and SDS-polyacrylamide gel electrophoresis. Twenty-four white rats were anesthetized. The right eye of each rat was injected with periocular CAC (1 mL) and the left eye with NMC (1 mL) by a trained ophthalmologist. Four mice each were euthanatized at days 1, 2, 3, 5, 7, 14, and 21 and both eyes were enucleated. The intravitreal concentrations of commercial carboplatin and nanomolecule carboplatin were determined with HPLC (high-performance liquid chromatography). Data were analyzed with the paired t-test. The main outcome measure was intravitreal concentrations CAC and NMC over time.
Results: The NMC vitreal concentration was higher than the CAC concentrations in all animals, until day 7 (P = 0.0001). On days 14 and 21, the CAC vitreal concentration was higher than the NMC concentrations in all animals (P = 0.0002). Overall, the mean vitreal concentration of NMC was greater than CAC.
Conclusions: Nanoparticulate-bound carboplatin has greater transscleral transport than commercially available carboplatin, especially in the first week after injection and may help enhance the proven adjuvant efficacy of periocular carboplatin over and above systemic chemotherapy in treating human retinoblastoma, especially those with vitreal seeds. This trial is being published to establish a proof of principle for this method of therapy.
Similar articles
-
Carboplatin loaded polymethylmethacrylate nano-particles in an adjunctive role in retinoblastoma: an animal trial.Indian J Ophthalmol. 2014 May;62(5):585-9. doi: 10.4103/0301-4738.129792. Indian J Ophthalmol. 2014. PMID: 24881606 Free PMC article.
-
Pharmacokinetics of systemic versus focal Carboplatin chemotherapy in the rabbit eye: possible implication in the treatment of retinoblastoma.Invest Ophthalmol Vis Sci. 2004 Oct;45(10):3644-9. doi: 10.1167/iovs.04-0228. Invest Ophthalmol Vis Sci. 2004. PMID: 15452072
-
In vivo intraocular distribution and safety of periocular nanoparticle carboplatin for treatment of advanced retinoblastoma in humans.Am J Ophthalmol. 2014 May;157(5):1109-15. doi: 10.1016/j.ajo.2014.01.027. Epub 2014 Feb 4. Am J Ophthalmol. 2014. PMID: 24503408 Clinical Trial.
-
Pharmacokinetic analysis of topotecan after intra-vitreal injection. Implications for retinoblastoma treatment.Exp Eye Res. 2010 Jul;91(1):9-14. doi: 10.1016/j.exer.2010.03.009. Epub 2010 Mar 20. Exp Eye Res. 2010. PMID: 20307538
-
Clearance of intravitreal voriconazole.Invest Ophthalmol Vis Sci. 2007 May;48(5):2238-41. doi: 10.1167/iovs.06-1362. Invest Ophthalmol Vis Sci. 2007. PMID: 17460285
Cited by
-
Lactoferrin, a unique molecule with diverse therapeutical and nanotechnological applications.Int J Biol Macromol. 2020 Dec 1;164:1046-1060. doi: 10.1016/j.ijbiomac.2020.07.167. Epub 2020 Jul 22. Int J Biol Macromol. 2020. PMID: 32707283 Free PMC article. Review.
-
Retinoblastoma major review with updates on Middle East management protocols.Saudi J Ophthalmol. 2012 Apr;26(2):163-75. doi: 10.1016/j.sjopt.2012.03.002. Saudi J Ophthalmol. 2012. PMID: 23960988 Free PMC article.
-
Evaluation of Antiproliferative Activity, Safety and Biodistribution of Oxaliplatin and 5-Fluorouracil Loaded Lactoferrin Nanoparticles for the Management of Colon Adenocarcinoma: an In Vitro and an In Vivo Study.Pharm Res. 2018 Jul 16;35(9):178. doi: 10.1007/s11095-018-2457-7. Pharm Res. 2018. PMID: 30014319
-
The role of intravitreal chemotherapy for retinoblastoma.Indian J Ophthalmol. 2015 Feb;63(2):141-5. doi: 10.4103/0301-4738.154390. Indian J Ophthalmol. 2015. PMID: 25827545 Free PMC article. Review.
-
A novel treatment approach for retinoblastoma by targeting epithelial growth factor receptor expression with a shRNA lentiviral system.Iran J Basic Med Sci. 2017 Jul;20(7):739-744. doi: 10.22038/IJBMS.2017.9003. Iran J Basic Med Sci. 2017. PMID: 28852437 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources